SmithKline may make offer for Block Drug of U.S

Article Abstract:

SmithKline Beecham PLC is considering making a bid to acquire Block Drug Co. for approximately $1.2 billion (1.37 billion euros). SmithKline is just one of several top bidders for Block Drug.

United States, Foreign operations, Block Drug Company Inc., BLOCA

---

Boehringer Raises Stake In Japan's SSP to 35.86% (Germany's Borhringer Ingelheim KG buys a third of SSP Company Ltd., of Japan)

Article Abstract:

German pharmaceuticals company Boehringer Ingelheim KG has increased its stake in Japan's SSP Company Ltd., to more than a third of the company, from 19.6%.

Japan, Germany, Market information - general, Boehringer Ingelheim KG, SSP Company Ltd.

---

Glaxo, SmithKline merger forms world's largest drug company

Article Abstract:

Glaxo Wellcome PLC has completed its merger with SmithKline Beecham PLC, creating a new company, GlaxoSmithKline PLC, which has a market capitalization of roughly GBP114 billion (Euro181.96 billion).

Management, Glaxo Wellcome PLC, GlaxoSmithKline PLC

Similar abstracts:

• Abstracts: Pan-Europe exchange faces money pressure (Germany's Deutsche Borse AG and London Stock Exchange Ltd., merger plans)
• Abstracts: Cybersquatting: European companies are not amused by spread of bogus coporate sites. Retailers' ultimate cool tool: the mobile phone
• Abstracts: Boris Jordan faces many challenges as head of Russia's NTV station. Gusinsky may be sent back to Russia
• Abstracts: Unilever to cut jobs and close factories; consumer goods firm to focus on core brands. Unilever renames Jif to Cif in U.K. to simplify brand
• Abstracts: Uproar over return of bronze lion tied to 'scam ads' for Sydney zoo. No foreigners allowed?

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.